Adial Pharmaceuticals Current Assets

Adial Pharmaceuticals (ADIL) currently reports a current assets of $29M as of June 2026. That compares with $6.1M in the prior-year period — up 374.5% year over year. Use the charts on this page to explore Adial Pharmaceuticals's current assets history and peer comparisons.

Adial Pharmaceuticals's current assets increased from $6.1M to $29M — a 374.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Adial Pharmaceuticals reported $29M in current assets as of June 2026. That compares with $6.1M in the prior-year period — up 374.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $29M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Adial Pharmaceuticals, and consider following ADIL for alerts when major investors trade the stock.

Adial Pharmaceuticals is classified in the Healthcare sector. On current assets, it currently shows $29M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ADIL with unrelated industries.